e-learning
resources
Berlin 2001
Monday 24.09.2001
Pathophysiology of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Leptin in obstructive sleep apnea
M. A. Machnick, M. Haske, C. Flashar, W. Zidek, B. Sanner (Herne, Germany)
Source:
Annual Congress 2001 - Pathophysiology of OSA
Session:
Pathophysiology of OSA
Session type:
Poster Discussion
Number:
2215
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. A. Machnick, M. Haske, C. Flashar, W. Zidek, B. Sanner (Herne, Germany). Leptin in obstructive sleep apnea. Eur Respir J 2001; 16: Suppl. 31, 2215
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Cortisol metabolism in obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002
Catecholamine secretion in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005
Can leptin be used to treat obstructive sleep apnoea?
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
The velumount device for obstructive sleep apnoea
Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Year: 2009
Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 332s
Year: 2004
Insulin resistance in obstructive sleep apnea patients
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Albuminuria in children with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Change in PLMS after treatment of obstructive sleep apnea
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007
Screening for obstructive sleep apnea (OSA) in acromegaly
Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea
Year: 2020
Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
NT-proBNP in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 415s
Year: 2006
Awakening headaches are associated with obstructive sleep apnea
Source: Eur Respir J 2002; 20: Suppl. 38, 452s
Year: 2002
Comorbidities of obstructive sleep apnoea syndrome
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
ACE-inhibitors and obstructive sleep apnoea
Source: Eur Respir J 2005; 26: Suppl. 49, 358s
Year: 2005
Prevalence of complex sleep apnea among German patients with obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
The inflammation and insulin resistance in obstructive sleep apnea
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept